Crinetics Pharmaceuticals Inc.(CRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRNX Crinetics Pharmaceuticals Inc.

交易中 11-26 14:56:25 EST

55.96

-0.13

-0.23%

最高56.98	最低55.43	成交量19.14万
今开56.00	昨收56.09	日振幅2.76%
总市值51.90亿	流通市值47.34亿	总股本9,274万
成交额1,076万	换手率0.23%	流通股本8,460万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRNX","market":"US","secType":"STK","nameCN":"Crinetics Pharmaceuticals Inc.","latestPrice":55.96,"timestamp":1732650968002,"preClose":56.09,"halted":0,"volume":191359,"delay":0,"floatShares":84601200,"shares":92737627,"eps":-3.720422,"marketStatus":"交易中","marketStatusCode":2,"change":-0.13,"latestTime":"11-26 14:56:25 EST","open":56,"high":56.98,"low":55.431,"amount":10761666.960618,"amplitude":0.027616,"askPrice":56.12,"askSize":205,"bidPrice":55.96,"bidSize":132,"shortable":3,"etf":0,"ttmEps":-3.720422,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732654800000},"adr":0,"listingDate":1531886400000,"adjPreClose":56.09,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":57.58,"preClose":56.09,"latestTime":"04:32 EST","volume":1,"amount":57.58,"timestamp":1732613553125},"postHourTrading":{"tag":"盘后","latestPrice":56.0916,"preClose":56.09,"latestTime":"19:58 EST","volume":34630,"amount":1942381.433,"timestamp":1732582704299},"volumeRatio":0.335891,"impliedVol":0.3704,"impliedVolPercentile":0.0593},"requestUrl":"/m/hq/s/CRNX/wiki","defaultTab":"wiki","newsList":[{"id":"2484130629","title":"Crinetics Pharmaceuticals, Inc.2024财年第三财季实现净利润-76.83百万美元，同比减少33.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484130629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484130629?lang=zh_cn&edition=full","pubTime":"2024-11-19 18:00","pubTimestamp":1732010425,"startTime":"0","endTime":"0","summary":"11月19日，Crinetics Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第三财季净利润为-76.83百万美元，同比减少33.71%；其中营业收入为0.00美元，每股基本收益为-0.96美元。从资产负债表来看，Crinetics Pharmaceuticals, Inc.总负债1.04亿美元，其中短期债务7.41百万美元，资产负债比为9.01，流动比率为0.17。机构评级：截至2024年11月19日，当前有13家机构对Crinetics Pharmaceuticals, Inc.目标价做出预测，其中目标均价为74.77美元，其中最低目标价为55.00美元，最高目标价为97.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180135abcedf5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180135abcedf5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRNX"],"gpt_icon":0},{"id":"2483082300","title":"美国研究综述-AMN 医疗保健服务公司、Chart Industries 公司、家得宝公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2483082300","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483082300?lang=zh_cn&edition=full","pubTime":"2024-11-13 19:30","pubTimestamp":1731497406,"startTime":"0","endTime":"0","summary":"    路透11月13日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 AMN 医疗保健服务公司、Chart Industries 公司和家得宝公司。* 908 Devices Inc   ：Leerink Partners将目标价从12美元下调至4美元             * 908 Devices Inc   ：Leerink Partners 将其目标价从 \"跑赢大盘 \"下调至 \"跑输大盘\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSX","LU2133065610.SGD","BLTE","ALB","IRON","DAY","BBIO","ARCH","AMN","ABBV","LU0256863902.USD","BHVN","EWTX","COTY","LU2106854487.HKD","DOX","GTLS","BK4505","ALIT","ATLC","DCOM","HD","DOCS","FDX","CLF","HCSG","CHGG","AISP","ACLX","BK4566","CHH","CHRW","MASS","CCCS","SATS","AXSM","CRNX","AESI","LU2249611893.SGD","BK4534","COGT","BLFS","COLD","LU0128525689.USD","LU2065731478.USD","BK4567","BMY","CAVA","APA","BCAX"],"gpt_icon":0},{"id":"2475637498","title":"Crinetics Pharmaceuticals, Inc.盘中异动 大幅拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475637498","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475637498?lang=zh_cn&edition=full","pubTime":"2024-10-16 00:13","pubTimestamp":1729008811,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日00时13分，Crinetics Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.08%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.70%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016001331971a06d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016001331971a06d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRNX","BK4139"],"gpt_icon":0},{"id":"2474241460","title":"BUZZ-Crinetics Pharma 在定价发行更大规模股票后下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2474241460","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474241460?lang=zh_cn&edition=full","pubTime":"2024-10-09 20:07","pubTimestamp":1728475652,"startTime":"0","endTime":"0","summary":"    10月9日 - ** Crinetics Pharmaceuticals Inc  股价盘前下跌 2.8%，报 50.25 美元，因隔夜后续交易获得的股本多于目标股本。** 总部位于圣迭戈的公司于周二晚些时候以 50 美元的价格出售了  1000 万股股票，募集资金总额为 5 亿美元。** 截至本周二，CRNX 的股价已累计上涨约 45%。一年前股价为 26.80 美元","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRNX"],"gpt_icon":0},{"id":"2474859262","title":"BUZZ-Crinetics Pharma 因计划发行 4 亿美元股票而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2474859262","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474859262?lang=zh_cn&edition=full","pubTime":"2024-10-09 04:28","pubTimestamp":1728419319,"startTime":"0","endTime":"0","summary":"    10月8日 - ** Crinetics Pharmaceuticals Inc   股价盘后下跌 2.7%，报 50.31 美元，该公司正寻求股票融资** 总部位于圣地亚哥的药物开发商宣布  发行 4 亿美元股票** 公司打算将募集资金净额用于临床阶段候选产品的研发、商业化前活动和其他一般用途** 利瑞克和摩根士丹利担任账簿管理人** 该公司上个月向美国 FDA 提交了  新药申请，其主要候选药物 paltusotine 用于治疗肢端肥大症，这是一种罕见的疾病，患者体内会产生过多的生长激素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRNX"],"gpt_icon":0},{"id":"2460736821","title":"Crinetics Pharmaceuticals, Inc.2024财年第二财季实现净利润-74.06百万美元，同比减少45.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460736821","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460736821?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:02","pubTimestamp":1723910530,"startTime":"0","endTime":"0","summary":"8月18日，Crinetics Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第二财季净利润为-74.06百万美元，同比减少45.27%；其中营业收入为0.00美元，每股基本收益为-0.94美元。从资产负债表来看，Crinetics Pharmaceuticals, Inc.总负债1.05亿美元，其中短期债务7.45百万美元，资产负债比为8.92，流动比率为0.17。机构评级：截至2024年8月18日，当前有14家机构对Crinetics Pharmaceuticals, Inc.目标价做出预测，其中目标均价为69.21美元，其中最低目标价为48.00美元，最高目标价为97.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800033795a164ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800033795a164ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRNX"],"gpt_icon":0},{"id":"2458680321","title":"Crinetics Pharmaceuticals, Inc.盘中异动 临近收盘快速上涨5.27%报50.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458680321","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458680321?lang=zh_cn&edition=full","pubTime":"2024-08-09 03:54","pubTimestamp":1723146895,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日03时54分，Crinetics Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.27%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为3.70%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809035455aefdf595&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809035455aefdf595&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRNX"],"gpt_icon":0},{"id":"2457923834","title":"Crinetics Pharmaceuticals Inc    预计每股亏损 86 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457923834","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457923834?lang=zh_cn&edition=full","pubTime":"2024-08-07 10:01","pubTimestamp":1722996108,"startTime":"0","endTime":"0","summary":"   * Crinetics Pharmaceuticals Inc    预计将在 8 月 8 日公布截至 2024 年 6 月 30 日的季度收入报告。* LSEG 分析师对 Crinetics Pharmaceuticals Inc 的平均预期是每股亏损 86 美分。* 华尔街对 Crinetics Pharmaceuticals Inc 的 12 个月目标价中位数为 70.00 美元，高于其上次收盘价 50.20 美元。8月7日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Crinetics Pharmaceuticals Inc    预计每股亏损 86 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRNX"],"gpt_icon":0},{"id":"2457776829","title":"Crinetics Pharmaceuticals, Inc.盘中异动 快速跳水6.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457776829","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457776829?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:42","pubTimestamp":1722865324,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时42分，Crinetics Pharmaceuticals, Inc.股票出现异动，股价快速跳水6.15%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.13%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805214204957f34a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805214204957f34a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRNX"],"gpt_icon":0},{"id":"2455496689","title":"Crinetics Pharmaceuticals, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455496689","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455496689?lang=zh_cn&edition=full","pubTime":"2024-07-31 01:07","pubTimestamp":1722359232,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日01时07分，Crinetics Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.03%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Imunon, Inc.、Celularity Inc C/Wts 16/07/2026 、Processa Pharmaceuticals, Inc.涨幅较大，Processa Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.、Imunon, Inc.较为活跃，换手率分别为1906.90%、1504.47%、1258.48%，振幅较大的相关个股有Imunon, Inc.、Cns Pharmaceuticals, Inc.、Processa Pharmaceuticals, Inc.，振幅分别为78.15%、59.59%、55.88%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731010712af94dfbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731010712af94dfbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRNX"],"gpt_icon":0},{"id":"2450432088","title":"Crinetics Pharmaceuticals, Inc.盘中异动 快速上涨5.04%报50.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450432088","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450432088?lang=zh_cn&edition=full","pubTime":"2024-07-11 01:03","pubTimestamp":1720631003,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日01时03分，Crinetics Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.04%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.37%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。消息层面，截至01时03分，《Form 144 | Crinetics高管拟出售3,000股股份，价值约14.56万美元》资讯为影响Crinetics Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711010324aef90209&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711010324aef90209&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRPX","BK4139","CRNX","BK4007"],"gpt_icon":0},{"id":"2450020261","title":"Crinetics Pharmaceuticals, Inc.盘中异动 急速拉升5.14%报47.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450020261","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450020261?lang=zh_cn&edition=full","pubTime":"2024-07-10 00:15","pubTimestamp":1720541759,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日00时15分，Crinetics Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.14%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710001559941f5797&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710001559941f5797&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRNX"],"gpt_icon":0},{"id":"2450029756","title":"小摩：维持Crinetics Pharmaceuticals(CRNX.US)评级，由增持调整至增持评级, 目标价由47.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450029756","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450029756?lang=zh_cn&edition=full","pubTime":"2024-07-09 22:58","pubTimestamp":1720537122,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4534","LU0320765646.SGD","BK4585","LU2552382132.HKD","LU1668664300.SGD","IE0034235188.USD","BK4588","LU0310799852.SGD","LU1032466523.USD","LU0256863811.USD","LU0208291251.USD","LU1670627923.USD","LU0320765489.SGD","LU0496365809.HKD","LU2552382058.USD","LU0170899867.USD","LU0211327993.USD","LU1244550577.SGD","BK4581","IE00BKVL7J92.USD","LU1244550494.USD","LU1363072403.SGD","LU1162221912.USD","LU0234572021.USD","LU1261432733.SGD","IE00B3S45H60.SGD","BK4533","LU1670628061.USD","BK4139","LU0211331839.USD","SG9999002224.SGD","LU1974910355.USD","IE00B1BXHZ80.USD","LU1496350171.SGD","IE00BZ1G4Q59.USD","IE00BWXC8680.SGD","IE00B1XK9C88.USD","LU0238689110.USD","LU2552382215.SGD","LU0971096721.USD","LU0976567544.SGD","LU0149725797.USD","LU1496350502.SGD","BK4550","LU1914381329.SGD","LU0211328371.USD","LU0211326755.USD","CRNX","IE00B775SV38.USD","LU0070302665.USD"],"gpt_icon":0},{"id":"2450060385","title":"美国研究综述-Alphabet、多米诺比萨、McKesson","url":"https://stock-news.laohu8.com/highlight/detail?id=2450060385","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450060385?lang=zh_cn&edition=full","pubTime":"2024-07-09 14:49","pubTimestamp":1720507794,"startTime":"0","endTime":"0","summary":"    路透7月9日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Alphabet、Domino's Pizza 和 McKesson。要闻             * Alphabet Inc   ：杰富瑞将目标价从215美元上调至220美元             * Domino's Pizza Inc   ：贝尔德上调其评级至 \"跑赢大盘\"，目标价从530美元上调至580美元              * McKesson Corp   ：贝雅将目标价从679美元上调至694美元              * Teleflex Inc   ：Truist Securities将目标价从219美元上调至235美元             * Tradeweb Markets Inc   ：Raymond James将目标价从115美元上调至117美元  以下是路透周二报道的美国公司研究报告摘要。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","ZETA","LU0494093205.USD","CAH","BK4503","BK4576","COR","DVN","IE00BJTD4V19.USD","SG9999004303.SGD","TEM","BK4023","LU2087625088.SGD","LU0048573561.USD","SGXZ81514606.USD","LU0310800379.SGD","LU1430594728.SGD","LU2065169927.USD","LU0211328371.USD","TFX","LU1983260115.SGD","LU0127658192.USD","DYN","BK4585","EPR","KYMR","ACM","LU0889566641.SGD","MCK","BK4141","GOOGL","DPZ","EWTX","LU0320765059.SGD","LU2125154778.USD","DIN","LU0310800965.SGD","LU1267930730.SGD","LU0742534661.SGD","CMG","LU0170899867.USD","CGC","TW","BK4112","LU0149725797.USD","LU0006061336.USD","SIMO","IE00BKVL7J92.USD","BK4579","CRNX"],"gpt_icon":0},{"id":"2448916028","title":"Crinetics Pharmaceuticals, Inc.盘中异动 股价大涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448916028","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448916028?lang=zh_cn&edition=full","pubTime":"2024-07-01 22:26","pubTimestamp":1719844018,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日22时26分，Crinetics Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.22%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。消息层面，截至22时26分，《H.C. Wainwright维持Crinetics买入评级，维持目标价60美元》资讯为影响Crinetics Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701222658af9009cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701222658af9009cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRNX"],"gpt_icon":0},{"id":"2446139455","title":"Crinetics Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446139455","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446139455?lang=zh_cn&edition=full","pubTime":"2024-06-26 22:29","pubTimestamp":1719412193,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日22时29分，Crinetics Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.01%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.87%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626222953aef6c055&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626222953aef6c055&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRNX","BK4139"],"gpt_icon":0},{"id":"2443466567","title":"Crinetics Pharmaceuticals, Inc.盘中异动 下午盘快速拉升5.11%报47.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443466567","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2443466567?lang=zh_cn&edition=full","pubTime":"2024-06-13 01:03","pubTimestamp":1718211806,"startTime":"0","endTime":"0","summary":"北京时间2024年06月13日01时03分，Crinetics Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.11%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061301032696813c71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061301032696813c71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGVN","BK4139","CRNX"],"gpt_icon":0},{"id":"2440392112","title":"Crinetics Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440392112","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440392112?lang=zh_cn&edition=full","pubTime":"2024-06-04 22:16","pubTimestamp":1717510598,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日22时16分，Crinetics Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.08%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，Annexon, Inc.、Cingulate Inc C/Wts 10/12/2026 、天境生物涨幅较大，Bio-Path Holdings, Inc.、Fresh2 Group Limited、Annexon, Inc.较为活跃，换手率分别为57.39%、38.38%、32.37%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Annexon, Inc.、Silo Pharma, Inc.，振幅分别为181.00%、31.22%、28.08%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604221639941ec46d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604221639941ec46d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","CRNX","BK4139"],"gpt_icon":0},{"id":"2440282296","title":"摩根大通证券公司：重申Crinetics Pharmaceuticals(CRNX.US)评级由优于大市调整至优于大市评级, 目标价由80.","url":"https://stock-news.laohu8.com/highlight/detail?id=2440282296","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440282296?lang=zh_cn&edition=full","pubTime":"2024-06-04 20:20","pubTimestamp":1717503620,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CRNX","399975","BK4139","159848"],"gpt_icon":0},{"id":"2440289442","title":"HC Wainwright &amp; Co.：重申Crinetics Pharmaceuticals(CRNX.US)评级，由买入调整至买入评级, 目标价由60.","url":"https://stock-news.laohu8.com/highlight/detail?id=2440289442","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440289442?lang=zh_cn&edition=full","pubTime":"2024-06-04 19:26","pubTimestamp":1717500380,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","CRNX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.crinetics.com","stockEarnings":[{"period":"1week","weight":0.0445},{"period":"1month","weight":-0.0323},{"period":"3month","weight":0.0297},{"period":"6month","weight":0.2244},{"period":"1year","weight":0.7534},{"period":"ytd","weight":0.5764}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Crinetics Pharmaceuticals, Inc.于2008年11月18日根据特拉华州法律注册成立。该公司是一家临床阶段制药公司，致力于发现，开发和商业化用于治疗罕见内分泌疾病和内分泌相关肿瘤的新药。 内分泌途径的功能是保持体内平衡，并且通常使用通过G蛋白偶联受体或GPCRs起作用的肽激素来调节生理学的许多方面，包括生长，能量，代谢，胃肠功能和应激反应。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.081466},{"month":2,"riseRate":0.666667,"avgChangeRate":0.019442},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.046094},{"month":4,"riseRate":0.666667,"avgChangeRate":0.081043},{"month":5,"riseRate":0.666667,"avgChangeRate":-0.006472},{"month":6,"riseRate":0.666667,"avgChangeRate":0.007507},{"month":7,"riseRate":0.5,"avgChangeRate":-0.028721},{"month":8,"riseRate":0.428571,"avgChangeRate":0.05139},{"month":9,"riseRate":0.285714,"avgChangeRate":0.070664},{"month":10,"riseRate":0.428571,"avgChangeRate":0.002208},{"month":11,"riseRate":0.857143,"avgChangeRate":0.11025},{"month":12,"riseRate":0.833333,"avgChangeRate":0.063263}],"exchange":"NASDAQ","name":"Crinetics Pharmaceuticals Inc.","nameEN":"Crinetics Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Crinetics Pharmaceuticals Inc.(CRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Crinetics Pharmaceuticals Inc.(CRNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Crinetics Pharmaceuticals Inc.,CRNX,Crinetics Pharmaceuticals Inc.股票,Crinetics Pharmaceuticals Inc.股票老虎,Crinetics Pharmaceuticals Inc.股票老虎国际,Crinetics Pharmaceuticals Inc.行情,Crinetics Pharmaceuticals Inc.股票行情,Crinetics Pharmaceuticals Inc.股价,Crinetics Pharmaceuticals Inc.股市,Crinetics Pharmaceuticals Inc.股票价格,Crinetics Pharmaceuticals Inc.股票交易,Crinetics Pharmaceuticals Inc.股票购买,Crinetics Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Crinetics Pharmaceuticals Inc.(CRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Crinetics Pharmaceuticals Inc.(CRNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}